Joseph Marx is a corporate lawyer with a broad range of experience in securities transactions, international finance, complex commercial transactions, cross-border mergers and acquisitions, and general corporate law. He heads the firm’s Frankfurt office.
Joe has over 20 years of extensive experience in international capital markets transactions, including initial public offerings, rights issuances, accelerated primary and secondary offerings, Rule 144A transactions, US registered offerings, private placement transactions and debt offerings, as well as cross-border mergers and acquisitions, dual track processes and other corporate transactions. He has worked across a broad range of industries, including chemicals, life science, real estate and the automotive industry.
Joe also regularly advises clients on a wide variety of securities law and compliance issues, including the US securities law aspects of cross-border mergers and acquisitions. In addition, he provides general corporate counsel to international corporate clients in Asia, Europe and the United States.
Before practicing law, Joe served as a foreign policy assistant to former President Richard Nixon and as a speechwriter for President Bush’s 1992 re-election campaign.
Represented Joh. Berenberg, Gossler Co. & KG in a number of private placements in Europe and the United States via an accelerated bookbuilding process totalling over €1 billion.
Represented Aumann AG on its €251 million initial public offering on the Frankfurt Stock Exchange and a follow-on €80 million sale of shares in a private placement via an accelerated bookbuilding process with Citibank and Joh. Berenberg, Gossler Co. & KG as underwriters.
Represented Hauck & Aufhäuser Privatbankiers Aktiengesellschaft as underwriter counsel in the initial public offering of STS Group Holding AG on the Frankfurt Stock Exchange, including a Rule 144A offering in the United States.
Represented numerous life science companies in their international capital markets transactions, including Medigene AG, 4SC AG, Epigenomics AG and Heidelberg Pharma AG totalling over €500 million.
Represented Telefónica, S.A., in the €12.1 billion acquisition of the E-Plus Group from Royal KPN N.V. and fully underwritten rights offering of Telefónica Deutschland Holding AG to partially finance the acquisition of the E-Plus Group.
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.